RXDX logo

Prometheus Biosciences (RXDX) Free Cash Flow

Annual FCF

-$125.96 M
-$61.32 M-94.86%

December 31, 2022


Summary


Performance

RXDX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRXDXcash flowmetrics:

Quarterly FCF

-$40.07 M
+$1.42 M+3.42%

March 31, 2023


Summary


Performance

RXDX Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRXDXcash flowmetrics:

TTM FCF

-$135.69 M
-$9.73 M-7.73%

March 31, 2023


Summary


Performance

RXDX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRXDXcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

RXDX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-94.9%-32.1%-79.3%
3 y3 years-515.1%-638.0%-2398.9%
5 y5 years-515.1%-638.0%-2398.9%

RXDX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+94.9%at low+79.2%+3.5%+109.9%at low
5 y5-year+515.1%at low+775.2%+3.5%+2398.9%at low
alltimeall time+515.1%at low+775.2%+3.5%+2398.9%at low

Prometheus Biosciences Free Cash Flow History

DateAnnualQuarterlyTTM
Mar 2023
-
-$40.07 M(-3.4%)
-$135.69 M(+7.7%)
Dec 2022
-$125.96 M(+94.9%)
-$41.49 M(+70.1%)
-$125.96 M(+17.9%)
Sep 2022
-
-$24.39 M(-18.0%)
-$106.83 M(+7.1%)
Jun 2022
-
-$29.73 M(-2.0%)
-$99.79 M(+31.8%)
Mar 2022
-
-$30.34 M(+35.7%)
-$75.69 M(+17.1%)
Dec 2021
-$64.64 M
-$22.37 M(+29.0%)
-$64.64 M(+35.9%)
Sep 2021
-
-$17.34 M(+207.6%)
-$47.57 M(+36.7%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$5.64 M(-70.8%)
-$34.81 M(-17.3%)
Mar 2021
-
-$19.29 M(+264.3%)
-$42.08 M(+49.1%)
Dec 2020
-$28.22 M(+37.8%)
-$5.30 M(+15.7%)
-$28.22 M(+23.1%)
Sep 2020
-
-$4.58 M(-64.6%)
-$22.93 M(+25.0%)
Jun 2020
-
-$12.92 M(+137.9%)
-$18.35 M(+237.9%)
Mar 2020
-
-$5.43 M
-$5.43 M
Dec 2019
-$20.48 M
-
-

FAQ

  • What is Prometheus Biosciences annual free cash flow?
  • What is the all time high annual FCF for Prometheus Biosciences?
  • What is Prometheus Biosciences annual FCF year-on-year change?
  • What is Prometheus Biosciences quarterly free cash flow?
  • What is the all time high quarterly FCF for Prometheus Biosciences?
  • What is Prometheus Biosciences quarterly FCF year-on-year change?
  • What is Prometheus Biosciences TTM free cash flow?
  • What is the all time high TTM FCF for Prometheus Biosciences?
  • What is Prometheus Biosciences TTM FCF year-on-year change?

What is Prometheus Biosciences annual free cash flow?

The current annual FCF of RXDX is -$125.96 M

What is the all time high annual FCF for Prometheus Biosciences?

Prometheus Biosciences all-time high annual free cash flow is -$20.48 M

What is Prometheus Biosciences annual FCF year-on-year change?

Over the past year, RXDX annual free cash flow has changed by -$61.32 M (-94.86%)

What is Prometheus Biosciences quarterly free cash flow?

The current quarterly FCF of RXDX is -$40.07 M

What is the all time high quarterly FCF for Prometheus Biosciences?

Prometheus Biosciences all-time high quarterly free cash flow is -$4.58 M

What is Prometheus Biosciences quarterly FCF year-on-year change?

Over the past year, RXDX quarterly free cash flow has changed by -$9.73 M (-32.07%)

What is Prometheus Biosciences TTM free cash flow?

The current TTM FCF of RXDX is -$135.69 M

What is the all time high TTM FCF for Prometheus Biosciences?

Prometheus Biosciences all-time high TTM free cash flow is -$5.43 M

What is Prometheus Biosciences TTM FCF year-on-year change?

Over the past year, RXDX TTM free cash flow has changed by -$60.00 M (-79.26%)